Pharma giants explain stance on new clinical trials in Russia

Pharma giants explain stance on new clinical trials in Russia

The likes of Pfizer and Lilly have announced the halting of research in light of Moscow’s offensive against Ukraine Several major international pharmaceutical companies including Pfizer, Lilly and Sanofi have issued statements, announcing the suspension of new clinical trials in Russia in light of its military campaign against Ukraine.

Comments

Write a comment